Adalimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF_). Adalimumab has been used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.